Icosavax, Inc.·4

Feb 14, 7:08 PM ET

Russo Thomas Joseph 4

4 · Icosavax, Inc. · Filed Feb 14, 2022

Insider Transaction Report

Form 4
Period: 2015-02-10
Russo Thomas Joseph
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-10+74,50074,500 total
    Exercise: $17.55Exp: 2032-02-09Common Stock (74,500 underlying)
  • Award

    Common Stock

    2022-02-10+17,71451,880 total
Footnotes (3)
  • [F1]Represents restricted stock units ("RSUs") which will vest as to 25% of the total number of RSUs granted on each of the first four anniversaries of February 10, 2022, subject to the reporting persons continued service through the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer and the RSUs have no expiration date.
  • [F2]Includes 1,666 shares acquired under the Issuer's employee stock purchase plan on November 30, 2021.
  • [F3]25% of the shares subject to the option will vest on February 10, 2023, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the reporting person's continued service through the applicable vesting date.

Documents

2 files